Literature DB >> 9256902

Spontaneous regression of metastatic renal cancer. Case report and literature review.

J Lokich1.   

Abstract

A case of spontaneous regression of pleural and intrapulmonary metastases from renal cell cancer is reported with more than 60 cases reported since the original review of this clinical phenomenon in 1964. The metastatic disease sites are most often pulmonary, but extrapulmonary sites include liver, bone, and CNS regressions. The role of nephrectomy in "spontaneous regression" continues to be obscure, accounting for < 50% of documented cases. Immunologic mechanisms, although intellectually attractive, have not been identified.

Entities:  

Mesh:

Year:  1997        PMID: 9256902     DOI: 10.1097/00000421-199708000-00020

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  29 in total

1.  Spontaneous regression of bone metastasis from renal cell carcinoma; a case report.

Authors:  Takahiro Nakajima; Makoto Suzuki; Soichiro Ando; Tomohiko Iida; Akinobu Araki; Takehiko Fujisawa; Hideki Kimura
Journal:  BMC Cancer       Date:  2006-01-13       Impact factor: 4.430

2.  Active surveillance for metastatic or recurrent renal cell carcinoma.

Authors:  Inkeun Park; Jae-Lyun Lee; Jin-Hee Ahn; Dae-Ho Lee; Kyoo-Hyung Lee; In Gab Jeong; Cheryn Song; Bumsik Hong; Jun Hyuk Hong; Hanjong Ahn
Journal:  J Cancer Res Clin Oncol       Date:  2014-04-22       Impact factor: 4.553

3.  Intravenously administered vitamin C as cancer therapy: three cases.

Authors:  Sebastian J Padayatty; Hugh D Riordan; Stephen M Hewitt; Arie Katz; L John Hoffer; Mark Levine
Journal:  CMAJ       Date:  2006-03-28       Impact factor: 8.262

Review 4.  Moving beyond vascular endothelial growth factor-targeted therapy in renal cell cancer: latest evidence and therapeutic implications.

Authors:  Che-Kai Tsao; Bobby Liaw; Catherine He; Matthew D Galsky; John Sfakianos; William K Oh
Journal:  Ther Adv Med Oncol       Date:  2017-02-14       Impact factor: 8.168

5.  Metastatic Renal Cell Cancer-Systemic Therapy.

Authors:  Amit Joshi; Arvind Sahu; Vanita Noronha; Vijay Patil; Kumar Prabhash
Journal:  Indian J Surg Oncol       Date:  2018-01-29

6.  Carcinogenesis of renal cell carcinoma reflected in HLA ligands: A novel approach for synergistic peptide vaccination design.

Authors:  Martin G Klatt; Daniel J Kowalewski; Heiko Schuster; Moreno Di Marco; Jörg Hennenlotter; Arnulf Stenzl; Hans-Georg Rammensee; Stefan Stevanović
Journal:  Oncoimmunology       Date:  2016-06-30       Impact factor: 8.110

7.  DLK1: a novel target for immunotherapeutic remodeling of the tumor blood vasculature.

Authors:  Nina Chi Sabins; Jennifer L Taylor; Kellsye P L Fabian; Leonard J Appleman; Jodi K Maranchie; Donna Beer Stolz; Walter J Storkus
Journal:  Mol Ther       Date:  2013-07-30       Impact factor: 11.454

8.  Spontaneous regression of multiple pulmonary nodules in a patient with unclassified renal cell carcinoma following laparoscopic partial nephrectomy: A case report.

Authors:  Kosuke Ueda; Shigetaka Suekane; Tomotaro Mitani; Katsuaki Chikui; Kazuhisa Ejima; Shunsuke Suyama; Makoto Nakiri; Kiyoaki Nishihara; Mitsunori Matsuo; Tsukasa Igawa
Journal:  Mol Clin Oncol       Date:  2016-05-11

9.  Spontaneous regression of pulmonary and adrenal metastases following percutaneous radiofrequency ablation of a recurrent renal cell carcinoma.

Authors:  Heejung Kim; Byung Kwan Park; Chan Kyo Kim
Journal:  Korean J Radiol       Date:  2008 Sep-Oct       Impact factor: 3.500

10.  Paraneoplastic oesophageal dysmotility-renal cell carcinoma presenting as dysphagia: a case report.

Authors:  Mahesh D Bhalme; Scott E Levison; Gurvinder S Banait
Journal:  Cases J       Date:  2009-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.